載入...
Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives
Patients with advanced non-small cell lung cancer receive first-line therapy with chemotherapy, targeted therapies in case of tumors with driver mutations, and more recently also immune checkpoint inhibitors. Important controversies include the role of targeted therapies in combination with chemothe...
Na minha lista:
| 發表在: | Memo |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Vienna
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006273/ https://ncbi.nlm.nih.gov/pubmed/29983826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0408-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|